Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes

被引：0
|
作者：
Irit Hochberg
Elliot M. Berinstein
Uzi Milman
Chen Shapira
Andrew P. Levy
机构：
[1] Rambam HealthCare Campus,Institute of Endocrinology, Diabetes and Metabolism
[2] Technion Israel Institute of Technology,Technion Faculty of Medicine
[3] Clalit Health Services,undefined
来源：
Current Diabetes Reports | 2017年 / 17卷
关键词：
Vitamin E; Haptoglobin; Cardiovascular disease; High-density lipoproteins; Oxidative stress;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes
    Hochberg, Irit
    Berinstein, Elliot M.
    Milman, Uzi
    Shapira, Chen
    Levy, Andrew P.
    CURRENT DIABETES REPORTS, 2017, 17 (06)
  • [2] Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype
    Blum, Shany
    Vardi, Moshe
    Brown, Jonathan B.
    Russell, Allen
    Milman, Uzi
    Shapira, Chen
    Levy, Nina S.
    Miller-Lotan, Rachel
    Asleh, Rabea
    Levy, Andrew P.
    PHARMACOGENOMICS, 2010, 11 (05) : 675 - 684
  • [3] Vitamin E Reduces Cardiovascular Disease in Individuals With Diabetes Mellitus and the Haptoglobin 2-2 Genotype
    Blum, Shany
    Vardi, Moshe
    Brown, Jonathan
    Russell, Allen
    Milman, Uzi
    Shapira, Chen
    Levy, Nina
    Miller-Lotan, Rachel
    Asleh, Rabea
    Levy, Andrew
    CIRCULATION, 2009, 120 (18) : S420 - S420
  • [4] Targeting HDL Quality Rather than Quantity: Providing the Mechanistic Rationale for the Pharmacogenomic Interaction between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease In Individuals with Diabetes Mellitus
    Asleh, Robes O.
    Blum, Shany
    Kalet-Litman, Shiri
    Aviram, Michael
    Levy, Andrew P.
    CIRCULATION, 2008, 118 (18) : S305 - S306
  • [5] Pharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability
    Veiner, Hilla-Lee
    Gorbatov, Rostic
    Vardi, Moshe
    Doros, Gheorghe
    Miller-Lotan, Rachel
    Zohar, Yaniv
    Sabo, Edmond
    Asleh, Rabea
    Levy, Nina S.
    Goldfarb, Levi J.
    Berk, Thomas A.
    Haas, Tali
    Shalom, Hadar
    Suss-Toby, Edith
    Kam, Adi
    Kaplan, Marielle
    Tamir, Ronit
    Ziskind, Anna
    Levy, Andrew P.
    ATHEROSCLEROSIS, 2015, 239 (01) : 232 - 239
  • [6] Is It Time to Screen for the Haptoglobin Genotype to Assess the Cardiovascular Risk Profile and Vitamin E Therapy Responsiveness in Patients with Diabetes?
    Vardi, Moshe
    Levy, Andrew P.
    CURRENT DIABETES REPORTS, 2012, 12 (03) : 274 - 279
  • [7] Is It Time to Screen for the Haptoglobin Genotype to Assess the Cardiovascular Risk Profile and Vitamin E Therapy Responsiveness in Patients with Diabetes?
    Moshe Vardi
    Andrew P. Levy
    Current Diabetes Reports, 2012, 12 : 274 - 279
  • [8] Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature
    Vardi, Moshe
    Blum, Shany
    Levy, Andrew P.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (07) : 628 - 632
  • [9] Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation
    Asleh, Rabea
    Briasoulis, Alexandros
    Berinstein, Elliot M.
    Wiener, Joshua B.
    Palla, Mohan
    Kushwaha, Sudhir S.
    Levy, Andrew P.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2018, 11 : 71 - 82
  • [10] Haptoglobin Genotype and Its Role in Diabetic Cardiovascular Disease
    Tina Costacou
    Andrew P. Levy
    Journal of Cardiovascular Translational Research, 2012, 5 : 423 - 435
12345